ES434079A1 - Procedimiento para la obtencion de compuestos indolicos sus-tituidos. - Google Patents

Procedimiento para la obtencion de compuestos indolicos sus-tituidos.

Info

Publication number
ES434079A1
ES434079A1 ES434079A ES434079A ES434079A1 ES 434079 A1 ES434079 A1 ES 434079A1 ES 434079 A ES434079 A ES 434079A ES 434079 A ES434079 A ES 434079A ES 434079 A1 ES434079 A1 ES 434079A1
Authority
ES
Spain
Prior art keywords
substituted
group
indole
residue
aliphatic hydrocarbon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES434079A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES434079A1 publication Critical patent/ES434079A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES434079A 1974-01-25 1975-01-23 Procedimiento para la obtencion de compuestos indolicos sus-tituidos. Expired ES434079A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH104774 1974-01-25

Publications (1)

Publication Number Publication Date
ES434079A1 true ES434079A1 (es) 1977-03-01

Family

ID=4201215

Family Applications (1)

Application Number Title Priority Date Filing Date
ES434079A Expired ES434079A1 (es) 1974-01-25 1975-01-23 Procedimiento para la obtencion de compuestos indolicos sus-tituidos.

Country Status (14)

Country Link
JP (1) JPS50106969A (lv)
AT (1) ATA53175A (lv)
AU (1) AU7756375A (lv)
BE (1) BE824742A (lv)
DE (1) DE2501468A1 (lv)
DK (1) DK3375A (lv)
ES (1) ES434079A1 (lv)
FR (1) FR2258853B1 (lv)
GB (1) GB1472342A (lv)
IE (1) IE40368B1 (lv)
IL (1) IL46505A0 (lv)
NL (1) NL7500535A (lv)
SE (1) SE7500262L (lv)
ZA (1) ZA75522B (lv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4999186A (en) * 1986-06-27 1991-03-12 The Procter & Gamble Company Novel sunscreen agents, sunscreen compositions and methods for preventing sunburn
CA2407677A1 (en) * 2000-04-28 2002-10-28 Baxter Healthcare Sa 2-acyl indol derivatives and their use as anti-tumour agents
DE10152306A1 (de) * 2001-10-26 2003-07-24 Asta Medica Ag 2-Acylindolderivate mit neuen therapeutisch wertvollen Eigenschaften
EP2207547A4 (en) * 2007-10-05 2010-11-17 Amira Pharmaceuticals Inc PROTEIN INHIBITORS THAT ACTIVATE 5-LIPOXYGENASE
DK2448938T5 (en) 2009-06-29 2015-10-05 Incyte Corp Pyrimidinones AS PI3K inhibitors
WO2011075643A1 (en) 2009-12-18 2011-06-23 Incyte Corporation Substituted heteroaryl fused derivatives as pi3k inhibitors
TW201130842A (en) 2009-12-18 2011-09-16 Incyte Corp Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors
WO2011130342A1 (en) 2010-04-14 2011-10-20 Incyte Corporation FUSED DERIVATIVES AS ΡI3Κδ INHIBITORS
WO2011163195A1 (en) 2010-06-21 2011-12-29 Incyte Corporation Fused pyrrole derivatives as pi3k inhibitors
JP5961187B2 (ja) 2010-12-20 2016-08-02 インサイト・ホールディングス・コーポレイションIncyte Holdings Corporation Pi3k阻害剤としてのn−(1−(置換フェニル)エチル)−9h−プリン−6−アミン
US9108984B2 (en) 2011-03-14 2015-08-18 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
US9126948B2 (en) 2011-03-25 2015-09-08 Incyte Holdings Corporation Pyrimidine-4,6-diamine derivatives as PI3K inhibitors
EP3513793B1 (en) 2011-09-02 2021-03-10 Incyte Holdings Corporation Heterocyclylamines as pi3k inhibitors
AR090548A1 (es) 2012-04-02 2014-11-19 Incyte Corp Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
US10077277B2 (en) 2014-06-11 2018-09-18 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
HUE053025T2 (hu) 2015-02-27 2021-06-28 Incyte Corp Sók és eljárások PI3K inhibitor elõállítására
WO2016183060A1 (en) 2015-05-11 2016-11-17 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
US9988401B2 (en) 2015-05-11 2018-06-05 Incyte Corporation Crystalline forms of a PI3K inhibitor

Also Published As

Publication number Publication date
DK3375A (lv) 1975-09-15
SE7500262L (lv) 1975-07-28
AU7756375A (en) 1976-07-29
IL46505A0 (en) 1975-04-25
BE824742A (fr) 1975-07-24
FR2258853A1 (lv) 1975-08-22
FR2258853B1 (lv) 1978-06-30
GB1472342A (en) 1977-05-04
IE40368B1 (en) 1979-05-09
DE2501468A1 (de) 1975-07-31
ATA53175A (de) 1977-08-15
IE40368L (en) 1975-07-25
NL7500535A (nl) 1975-07-29
JPS50106969A (lv) 1975-08-22
ZA75522B (en) 1976-01-28

Similar Documents

Publication Publication Date Title
ES434079A1 (es) Procedimiento para la obtencion de compuestos indolicos sus-tituidos.
ES320294A1 (es) Procedimiento para la preparacion de nuevos derivados del indol.
ES401623A1 (es) Procedimiento para la obtencion de derivados de adenosina.
ES390979A1 (es) Procedimiento para la obtencion de derivados del acido n- fluordiclorometiltio-sulfamidico.
ES394562A1 (es) Un procedimiento para la preparacion de nuevos imidazoles.
ES372536A1 (es) Procedimiento para la obtencion de 6-amino - 4,5 - dihidro - isotiazolo (4,5-d) pirimidinas.
ES328674A1 (es) Procedimiento para la produccion de alcaloides.
ES378206A1 (es) Procedimiento para la preparacion de nuevos 2-amino-5-ni- trotiazoles.
ES394533A1 (es) Procedimiento para la obtencion de compuestos de 2-hidroxi-4'-fenoxibenzofenona.
ES369751A1 (es) Procedimiento para la preparacion de nuevos derivados de indol.
ES430417A1 (es) Procedimiento para preparar bromuro de amidoalquil-trifenil-fosfonio.
ES402117A1 (es) Procedimiento para la obtencion de derivados de 2-fenil-2- imidazolina.
ES462774A1 (es) Procedimiento para la obtencion de nuevos ftalil derivados de sulfamidas.
ES382623A1 (es) Procedimiento para la preparacion de nuevos derivados de i-midazolidinona.
ES460932A3 (es) Un procedimiento para la preparacion de compuestos derivadosde indol.
ES289751A1 (es) Procedimiento para la obtenciën de granulados minusculos
ES382612A1 (es) Procedimiento para la preparacion de nuevos derivados de imidazolidinona.
ES433843A1 (es) Procedimiento para la obtencion de nuevos compuestos micro-bicidas.
ES351328A1 (es) Procedimiento para la preparacion de los derivados de pros-cilaridina a.
ES313506A1 (es) Procedimiento para la obtencion de derivados hidracinicos.
ES378756A1 (es) Procedimiento para la preparacion de nuevos derivados de isoquinoleina.
ES398186A1 (es) Procedimiento para la preparacion de 3-slfoalquil-6-hidro- xi-piridonas-(2).
ES325525A1 (es) Un procedimiento para la sintesis de compuestos piridazinicos.
ES396389A1 (es) Procedimiento para la obtencion de compuestos de acido 7-a-cilamino-cef-3-em-4-carboxilico.
ES377601A2 (es) Procedimiento para la obtencion e acidos carboxilicos alfa-(amino-fenil)-alifaticos